Investment firm Zrosk buys 10% stake in Lagos-based drugmaker MeCure

  • 📰 PremiumTimesng
  • ⏱ Reading Time:
  • 38 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 18%
  • Publisher: 78%

ایران اخبار اخبار

ایران آخرین اخبار,ایران سرفصلها

MeCure said the off-market deal was finalised, following clearance from the NGX.

How Ukraine’s Superhuman Centre is helping war heroes walk againThe paradox of declining optimism, By Bolutife OluwadeleDangote Refinery, MPR hike and matters arising, By Abdulhaleem RingimHow Ukraine’s Superhuman Centre is helping war heroes walk againThe paradox of declining optimism, By Bolutife OluwadeleDangote Refinery, MPR hike and matters arising, By Abdulhaleem RingimZrosk Investment Management Limited, a firm of investment managers focusing on Africa, has taken a 10 per cent ownership...

Balance sheet size as of June was N52.9 billion, while market value at the start of trade on Friday stood at N33.6 billion. “One of our core convictions at Zrosk IM is that ownership on the African continent is shifting towards indigenous hands. We view the stock market as a theatre of such transition, and we see MeCure Industries as a potential dominant player in the pharmaceutical value chain on the continent,” Samson Esemuede, Zrosk’s managing director, said.

At Premium Times, we firmly believe in the importance of high-quality journalism. Recognizing that not everyone can afford costly news subscriptions, we are dedicated to delivering meticulously researched, fact-checked news that remains freely accessible to all.

این خبر را خلاصه کرده ایم تا بتوانید سریع آن را بخوانید. اگر به خبر علاقه مند هستید، می توانید متن کامل را اینجا بخوانید. ادامه مطلب:

 /  🏆 3. in İR
 

از نظر شما متشکرم. نظر شما پس از بررسی منتشر خواهد شد.

ایران آخرین اخبار, ایران سرفصلها